EPGNY Tiesioginiai signalai | Didinkite pelną su Getagraph.com

Live Chart Being Loaded With Signals

Commentary (21 rugs. 2022 @ 21:34):

Stats
Šios dienos apimtis	212.00
Vidutinė apimtis	9.00
Rinkos kapitalizacija	0.00
Last Dividend	$0.0297 ( 2021-09-16 )
Next Dividend	$0 ( N/A )
P/E	-1.604
ATR14	$0 (0.00%)

Epigenomics AG Koreliacija

10 Labiausiai teigiamai susiję koreliacijos

10 Labiausiai neigiamai susiję koreliacijos

Ar žinojote?

Koreliacija yra statistinis rodiklis, aprašantis ryšį tarp dviejų kintamųjų. Jis svyruoja nuo -1 iki 1, kur -1 reiškia tobulo neigiamo ryšio koreliaciją (padidėjus vienam kintamajam, sumažėja kitas), 1 reiškia tobulo teigiamo ryšio koreliaciją (padidėjus vienam kintamajam, padidėja ir kitas), o 0 reiškia jokios koreliacijos (tarp kintamųjų nėra jokio ryšio).

Koreliacija gali būti naudojama analizuojant bet kurių dviejų kintamųjų ryšį, ne tik akcijų. Jis dažnai naudojamas finansų, ekonomikos, psichologijos ir kitose srityse.

Epigenomics AG Finansinės ataskaitos

Annual	2021
Pajamos:	$6.20M
Bruto pelnas:	$6.07M (97.81 %)
EPS:	$-0.271

FY	2021
Pajamos:	$6.20M
Bruto pelnas:	$6.07M (97.81 %)
EPS:	$-0.271

FY	2020
Pajamos:	$842 000
Bruto pelnas:	$697 000 (82.78 %)
EPS:	$-2.48

FY	2019
Pajamos:	$1.13M
Bruto pelnas:	$872 000 (77.51 %)
EPS:	$-4.48

Financial Reports:

No articles found.

Epigenomics AG Dividends

(Q3/22)	(Q4/22)	(Q1/23)	(Q2/23)	(Q3/23)	(Q4/23)	(Q1/24)	(Q2/24)	(Q3/24)	(Q4/24)
$0 (N/A)	$0 (N/A)	$0 (N/A)	$0 (N/A)	$0 (N/A)	$0 (N/A)	$0 (N/A)	$0 (N/A)	$0 (N/A)	$0 (N/A)

Epigenomics AG Dividend Information - No Dividend Player

Dividend Sustainability Score: 0.458 - low (50.00%) | Divividend Growth Potential Score: 0 - No dividend growth expected in the near future

Information

First Dividend	$0.833	2018-10-31
Last Dividend	$0.0297	2021-09-16
Next Dividend	$0	N/A
Payout Date	0000-00-00
Next Payout Date	N/A
# dividends	5	--
Total Paid Out	$2.72	--
Avg. Dividend % Per Year	0.00%	--
Score	0.55	--
Div. Sustainability Score	0.458
Div.Growth Potential Score	0
Div. Directional Score	0	--

Next Divdend (Est)
(2024-09-23)

$0 Estimate 0.00 %

Dividend Stability

0.05 Very Bad

Dividend Score

0.55

Pay Frequency

Annually

Yearly Payout

Year	Amount	Yield

Dividend Commentary

The company's low Dividend Sustainability Score (DSS) highlights potential challenges in upholding its current dividend levels. Unfortunately, its low Dividend Growth Potential Score (DGPS) suggests limited prospects for dividend growth. In conclusion, a more vigilant stance is recommended given the company's tentative dividend landscape.

Top 10 dividend Companies for OTC

Symbol	Title	Last dividend	Frequency	Yearly Dividend
TTNDF	Ex Dividend Knight	2023-08-29	Annually	0.00%
IVSBF	Ex Dividend Knight	2023-11-03	Annually	0.00%
BDORY	Ex Dividend Knight	2023-09-12	Bi-Monthly	0.00%
RBSFY	Ex Dividend Knight	2023-06-09	Annually	0.00%
EMSHF	Ex Dividend Knight	2023-08-15	Annually	0.00%
VWAPY	Ex Dividend Junior	2023-05-11	Annually	0.00%
KTHN	Ex Dividend Knight	2023-09-14	Quarterly	0.00%
CBCFF	Ex Dividend Junior	2024-03-28	Annually	0.00%
SEBC	Ex Dividend Junior	2023-08-30	Quarterly	0.00%
FOTB	Ex Dividend Junior	2023-05-31	Semi-Annually	0.00%

Dividend Sustainability Score (DSS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
netProfitMarginTTM	-0.391	1.500	-7.83	-10.00	[0 - 0.5]
returnOnAssetsTTM	-0.0984	1.200	-3.28	-3.94	[0 - 0.3]
returnOnEquityTTM	-0.187	1.500	-3.19	-4.78	[0.1 - 1]
payoutRatioTTM	0	-1.000	0	0	[0 - 1]
currentRatioTTM	11.06	0.800	10.00	8.00	[1 - 3]
quickRatioTTM	10.72	0.800	10.00	8.00	[0.8 - 2.5]
cashRatioTTM	10.72	1.500	10.00	10.00	[0.2 - 2]
debtRatioTTM	0.0187	-1.500	9.69	-10.00	[0 - 0.6]
interestCoverageTTM	-45.35	1.000	-10.00	-10.00	[3 - 30]
operatingCashFlowPerShareTTM	-0.463	2.00	-0.154	-0.309	[0 - 30]
freeCashFlowPerShareTTM	-0.467	2.00	-0.233	-0.467	[0 - 20]
debtEquityRatioTTM	0.0208	-1.500	9.92	-10.00	[0 - 2.5]
grossProfitMarginTTM	0.978	1.000	10.00	10.00	[0.2 - 0.8]
operatingProfitMarginTTM	-0.380	1.000	-9.60	-9.60	[0.1 - 0.6]
cashFlowToDebtRatioTTM	-9.03	1.000	-10.00	-10.00	[0.2 - 2]
assetTurnoverTTM	0.252	0.800	-1.657	-1.325	[0.5 - 2]
Total Score				0.458

Dividend Growth Score (DGS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
peRatioTTM	-8.20	1.000	-0.929	0	[1 - 100]
returnOnEquityTTM	-0.187	2.50	-2.05	-4.78	[0.1 - 1.5]
freeCashFlowPerShareTTM	-0.467	2.00	-0.156	-0.467	[0 - 30]
dividendYielPercentageTTM	0	1.500	0	0	[0 - 0.4]
operatingCashFlowPerShareTTM	-0.463	2.00	-0.154	-0.309	[0 - 30]
payoutRatioTTM	0	1.500	0	0	[0 - 1]
pegRatioTTM	2.03	1.500	10.00	0	[0.5 - 2]
operatingCashFlowSalesRatioTTM	-0.669	1.000	-10.00	0	[0.1 - 0.5]
Total Score				-0.667

Epigenomics AG

Epigenomics AG, a molecular diagnostics company, focuses on liquid biopsy for the early detection of cancer. Its lead product is Epi proColon, a blood-based test for the early detection of colorectal cancer in the United States, Europe, and China. The company's products also include hepatocellular carcinoma blood test; Epi proColon, a liquid biopsy test for detection of colorectal cancer; and Epi BiSKit, a pre-analytical tool, which provides a set of reagents for the preparation of bisulfite-converted DNA. Its research and development activities identify suitable biomarkers in human tissue and developing and patenting the corresponding in vitro diagnostic blood tests. Epigenomics AG was founded in 1998 and is headquartered in Berlin, Germany.